BCX-1777 in Treating Patients With Refractory Cutaneous T-Cell Lymphoma
Clinical trial NCT00061880 · COMPLETED
Trial details
- NCT number
- NCT00061880
- Sponsor
- BioCryst Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-02-01
- Primary completion
- 2005-01-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.